Publications by Dr Christopher Carey - ePrints

Browsing publications by Dr Christopher Carey.

Newcastle Authors	Title	Year
Dr Christopher Bacon Dr Christopher Carey	Lymphoma triage from H&E using AI for improved clinical management	2023
Dr Laura Jardine Dr Simone Webb Issac Goh Dr Gary Reynolds Dr Michael Mather et al.	Blood and immune development in human fetal bone marrow and Down syndrome	2021
Dr Gary Reynolds Dr Peter Vegh Dr James Fletcher Dr Beth Poyner Dr Emily Stephenson et al.	Developmental cell programs are co-opted in inflammatory skin disease	2021
Dr Meghan Acres Dr Gill Hulme Dr Christopher Carey Dr John Mansfield Emeritus Professor John Kirby et al.	Regulation and role of αE integrin and gut homing integrins in migration and retention of intestinal lymphocytes during inflammatory bowel disease	2021
Sarah Armour Dr Scott Anderson Dr Yuchun Ding Dr Christopher Carey Dr Rashmi Maheshwari et al.	Reduced expression of the co-regulator TLE1 in type 2 diabetes is associated with increased islet α-cell number	2020
Dr David Swan Professor Chris Lamb Dr Karin Engelhardt Dr Rui Chen Dr Yuchun Ding et al.	Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ	2019
Dr Christopher Carey	Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.	2017
Dr Christopher Carey	Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status	2017
Dr Christopher Carey	Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma	2017
Dr Christopher Carey	An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma	2016
Dr Christopher Carey Dr Rachel Crossland Dr Christopher Bacon Dr Vikki Rand	Molecular Classification of MYC-Driven B-Cell Lymphomas by Targeted Gene Expression Profiling of Fixed Biopsy Specimens	2015
Dr Christopher Carey	Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non–Small Cell Lung Cancer	2012